Methods Inf Med 2002; 41(03): 213-215
DOI: 10.1055/s-0038-1634437
Original Article
Schattauer GmbH

Validity of the Framingham Risk Model Applied to Japanese Men

M. Suka
1   Department of Preventive Medicine, St. Marianna University School of Medicine, Japan
H. Sugimori
1   Department of Preventive Medicine, St. Marianna University School of Medicine, Japan
K. Yoshida
1   Department of Preventive Medicine, St. Marianna University School of Medicine, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
08 February 2018 (online)


Objectives: To examine whether the Framingham Risk Model can appropriately predict coronary heart disease (CHD) events detected by electrocardiography (ECG) in Japanese men.

Methods: Using the annual health examination database of a Japanese company 5611 male workers, between the ages of 30 to 59, who were free of cardiovascular disease, were followed up to observe the occurrence of CHD events detected by ECG over a period of five to seven years. The probability of CHD was calculated for each individual from the equations of the Framingham risk model (with total cholesterol).

Results: The incidence of CHD increased with the estimated CHD risk. The Hosmer-Lemeshow goodness of fit test showed an adequate fit of the risk model to the data of the study subjects. In the receiver operating characteristic analysis, the area under the curve reached 0.67 which indicated an acceptable discriminatory accuracy of the risk model.

Conclusions: The Framingham risk model provides useful information on future CHD events in Japanese men.

  • References

  • 1 Health and Welfare Statistics Association. Trend of National Health; (Japanese): 1998
  • 2 Kannel W, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham study. Am J Cardiol 1976; 38: 46-51.
  • 3 ERICA Research Group.. Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA project. Eur Heart J 1991; 12: 291-7.
  • 4 The Task Force.. Prevention of coronary heart disease in clinical practice. Eur Heart J 1998; 19: 1434-503.
  • 5 Liao Y, McGee D, Cooper R, Sutkowski M. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999; 137: 837-45.
  • 6 Knuiman M, Vu H. Prediction of coronary heart disease mortality in Busselton Western Australia: an evaluation of the Framingham, national health epidemilogic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997; 51: 515-9.
  • 7 Wilson P, D’Agostino R, Levy D, Belanger A, Silbershatz H, Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
  • 8 Grundy S, Pasternak R, Greenland P, Smith SJ, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. Circulation 1999; 100: 1481-92.
  • 9 Greenland P, Grundy S, Pasternak R, Lenfant C. Problems on the pathway from risk assessment to risk reduction. 1998 97: 1761-2.
  • 10 Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar H. The electrocardiogram in population studies:A classification system. Circulation 1960; 21: 1160-75.
  • 11 Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc.; 1989
  • 12 Erdreich L, Lee E. Use of relative operating characteristic analysis in epidemiology: a method for dealing with subjective judgement. Am J Epidemiol 1981; 114: 649-62.
  • 13 Kannel W, Anderson K, McGee D, Degatano L, Stampfer M. Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham study. Am Heart J 1987; 113: 370-82.
  • 14 Bacquer D, Backer G, Kornitzer M, Myny K, Doyen Z, Blackburn H. Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women. J Am Coll Cardiol 1998; 32: 680-5.
  • 15 Crow R, Prineas R, Hannan P, Grandits G, Blackburn H. Prognostic associatons of Minnesota code serial electrocardiograhic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1997; 80: 138-44.
  • 16 Daviglus M, Liao Y, Greenland P, Dyer A, Liu K, Xie X. et al. Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: The Chicago western electric study. JAMA 1999; 281: 530-6.
  • 17 British Cardiac Society,. et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 (Suppl. 12) 1-29.